P53 pathway is a major determinant in the radiosensitizing effect of Palbociclib: Implication in cancer therapy. [electronic resource]
Producer: 20200214Description: 23-33 p. digitalISSN:- 1872-7980
- Ataxia Telangiectasia Mutated Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclin-Dependent Kinase 4 -- antagonists & inhibitors
- Cyclin-Dependent Kinase 6 -- antagonists & inhibitors
- Humans
- Piperazines -- pharmacology
- Pyridines -- pharmacology
- Radiation-Sensitizing Agents -- pharmacology
- Signal Transduction -- drug effects
- Tumor Suppressor Protein p53 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.